ReP USP - Resultado da busca

Artigo de periodico
Naphthoquinone derivatives as potential immunomodulators: prospective for COVID-19 treatment (2024)
Moraes, Vitor Tassara ; Caires, Franco Jazon ; Silva Neto, Pedro Vieira da ; Mendonça, Jacqueline Nakau ; Fraga-Silva, Thais Fernanda de Campos ; Fontanezi, Bianca Bueno; Marcato, Priscyla Daniely ; Bonato, Vânia Luiza Deperon ; Sorgi, Carlos Arterio ; Moraes, Luiz Alberto Beraldo ; Clososki, Giuliano Cesar
Source: RSC Advances. Unidades: FCFRP, FMRP, FFCLRP, RUSP
Subjects: COVID-19, VITAMINA K, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Vitor Tassara et al. Naphthoquinone derivatives as potential immunomodulators: prospective for COVID-19 treatment. RSC Advances, v. 14, n. 10, p. 6532-6541, 2024Tradução . . Disponível em: https://doi.org/10.1039/D3RA08173G. Acesso em: 29 jan. 2026.
APA
Moraes, V. T., Caires, F. J., Silva Neto, P. V. da, Mendonça, J. N., Fraga-Silva, T. F. de C., Fontanezi, B. B., et al. (2024). Naphthoquinone derivatives as potential immunomodulators: prospective for COVID-19 treatment. RSC Advances, 14( 10), 6532-6541. doi:10.1039/D3RA08173G
NLM
Moraes VT, Caires FJ, Silva Neto PV da, Mendonça JN, Fraga-Silva TF de C, Fontanezi BB, Marcato PD, Bonato VLD, Sorgi CA, Moraes LAB, Clososki GC. Naphthoquinone derivatives as potential immunomodulators: prospective for COVID-19 treatment [Internet]. RSC Advances. 2024 ; 14( 10): 6532-6541.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1039/D3RA08173G
Vancouver
Moraes VT, Caires FJ, Silva Neto PV da, Mendonça JN, Fraga-Silva TF de C, Fontanezi BB, Marcato PD, Bonato VLD, Sorgi CA, Moraes LAB, Clososki GC. Naphthoquinone derivatives as potential immunomodulators: prospective for COVID-19 treatment [Internet]. RSC Advances. 2024 ; 14( 10): 6532-6541.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1039/D3RA08173G
Artigo de periodico
Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men (2023)
Duarte-Silva, Murillo ; Oliveira, Camilla Narjara Simão; Fuzo, Carlos Alessandro ; Silva Neto, Pedro Vieira da; Toro, Diana Mota; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Fraga-Silva, Thais Fernanda de Campos ; Carvalho, Jonatan Constança Silva de; Santos Neto, Firmino Martins dos; Martins Júnior, Ronaldo Bragança; Arruda Neto, Eurico de; Vilar, Fernando Crivelenti; Degiovani, Augusto Marcussi; Ostini, Fátima M.; Feitosa, Marley Ribeiro; Parra, Rogério Serafim ; Gaspar, Gilberto Gambero ; Rocha, José Joaquim Ribeiro da; Féres, Omar; Fernandes, Ana Paula Morais ; Maruyama, Sandra Regina Costa; Russo, Elisa Maria de Sousa ; Bonato, Vânia Luiza Deperon ; Santos, Isabel Kinney Ferreira de Miranda ; Sorgi, Carlos Arterio ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena ; Cardoso, Cristina Ribeiro de Barros
Source: Brain, Behavior, and Immunity. Unidades: FMRP, FCFRP, EERP, FFCLRP
Subjects: TESTOSTERONA, DIIDROTESTOSTERONA, RECEPTORES ADRENÉRGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE-SILVA, Murillo et al. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men. Brain, Behavior, and Immunity, v. 114, p. 275-286, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbi.2023.08.026. Acesso em: 29 jan. 2026.
APA
Duarte-Silva, M., Oliveira, C. N. S., Fuzo, C. A., Silva Neto, P. V. da, Toro, D. M., Pimentel, V. E., et al. (2023). Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men. Brain, Behavior, and Immunity, 114, 275-286. doi:10.1016/j.bbi.2023.08.026
NLM
Duarte-Silva M, Oliveira CNS, Fuzo CA, Silva Neto PV da, Toro DM, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Carvalho JCS de, Santos Neto FM dos, Martins Júnior RB, Arruda Neto E de, Vilar FC, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Santos IKF de M, Sorgi CA, Dias-Baruffi M, Faccioli LH, Cardoso CR de B. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men [Internet]. Brain, Behavior, and Immunity. 2023 ; 114 275-286.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.bbi.2023.08.026
Vancouver
Duarte-Silva M, Oliveira CNS, Fuzo CA, Silva Neto PV da, Toro DM, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Carvalho JCS de, Santos Neto FM dos, Martins Júnior RB, Arruda Neto E de, Vilar FC, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Santos IKF de M, Sorgi CA, Dias-Baruffi M, Faccioli LH, Cardoso CR de B. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men [Internet]. Brain, Behavior, and Immunity. 2023 ; 114 275-286.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.bbi.2023.08.026
Artigo de periodico
The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 (2023)
Carvalho, Jonatan C. S. de; Silva Neto, Pedro Vieira da ; Toro, Diana Mota; Fuzo, Carlos Alessandro ; Nardini, Viviani ; Pimentel, Vinícius Eduardo ; Pérez, Malena Martínez ; Fraga-Silva, Thais Fernanda de Campos ; Oliveira, Camilla N. S.; Degiovani, Augusto Marcussi; Ostini, Fátima Magro; Feitosa, Marley Ribeiro ; Parra, Rogério Serafim ; Rocha, José Joaquim Ribeiro da ; Féres, Omar ; Vilar, Fernando Crivelenti ; Gaspar, Gilberto Gambero ; Santos, Isabel Kinney Ferreira de Miranda ; Fernandes, Ana Paula Morais ; Maruyama, Sandra Regina Costa ; Russo, Elisa Maria de Sousa ; Bonato, Vânia Luiza Deperon ; Cardoso, Cristina Ribeiro de Barros ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena ; Sorgi, Carlos Arterio
Source: Viruses. Unidades: FMRP, EERP, FCFRP, FFCLRP, FM
Subjects: COVID-19, HORMÔNIOS GLICOCORTICOIDES, FATOR DE ATIVAÇÃO DE PLAQUETAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Jonatan C. S. de et al. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19. Viruses, v. 15, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15020573. Acesso em: 29 jan. 2026.
APA
Carvalho, J. C. S. de, Silva Neto, P. V. da, Toro, D. M., Fuzo, C. A., Nardini, V., Pimentel, V. E., et al. (2023). The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19. Viruses, 15. doi:10.3390/v15020573
NLM
Carvalho JCS de, Silva Neto PV da, Toro DM, Fuzo CA, Nardini V, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Oliveira CNS, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Santos IKF de M, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Sorgi CA. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 [Internet]. Viruses. 2023 ; 15[citado 2026 jan. 29 ] Available from: https://doi.org/10.3390/v15020573
Vancouver
Carvalho JCS de, Silva Neto PV da, Toro DM, Fuzo CA, Nardini V, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Oliveira CNS, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Santos IKF de M, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Sorgi CA. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 [Internet]. Viruses. 2023 ; 15[citado 2026 jan. 29 ] Available from: https://doi.org/10.3390/v15020573
Artigo de periodico
The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature (2023)
Fuzo, Carlos Alessandro ; Silva, Thais Fernanda de Campos Fraga ; Maruyama, Sandra Regina Costa ; Bastos, Victor Alexandre Félix; Rogerio, Luana Aparecida; Takamiya, Nayore Tamie; Silva-Neto, Pedro V. da; Pimentel, Vinícius Eduardo; Toro, Diana Mota; Pérez, Malena Martínez ; Carvalho, Jonatan C S de; Carmona-Garcia, Ingryd; Oliveira, Camilla N. S.; Degiovani, Augusto Marcussi; Ostini, Fatima M.; Constant, Leticia F.; Amorim, Alessandro P. de; Vilar, Fernando Crivelenti ; Feitosa, Marley Ribeiro ; Parra, Rogério Serafim ; Rocha, José Joaquim Ribeiro da ; Féres, Omar ; Gaspar, Gilberto Gambero ; Viana, Angelina Lettiere ; Fernandes, Ana Paula Morais ; Santos, Isabel Kinney Ferreira de Miranda ; Russo, Elisa Maria de Sousa ; Cardoso, Cristina Ribeiro de Barros ; Sorgi, Carlos Arterio ; Faccioli, Lucia Helena ; Bonato, Vânia Luiza Deperon ; Baruffi, Marcelo Dias
Source: Immunology. Unidades: FMRP, EERP, FCFRP, FFCLRP
Subjects: BIOMARCADORES, COVID-19, NEUTRÓFILOS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUZO, Carlos Alessandro et al. The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature. Immunology, v. 169, p. 323-343, 2023Tradução . . Disponível em: https://doi.org/10.1111/imm.13631. Acesso em: 29 jan. 2026.
APA
Fuzo, C. A., Silva, T. F. de C. F., Maruyama, S. R. C., Bastos, V. A. F., Rogerio, L. A., Takamiya, N. T., et al. (2023). The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature. Immunology, 169, 323-343. doi:10.1111/imm.13631
NLM
Fuzo CA, Silva TF de CF, Maruyama SRC, Bastos VAF, Rogerio LA, Takamiya NT, Silva-Neto PV da, Pimentel VE, Toro DM, Pérez MM, Carvalho JCS de, Carmona-Garcia I, Oliveira CNS, Degiovani AM, Ostini FM, Constant LF, Amorim AP de, Vilar FC, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Gaspar GG, Viana AL, Fernandes APM, Santos IKF de M, Russo EM de S, Cardoso CR de B, Sorgi CA, Faccioli LH, Bonato VLD, Baruffi MD. The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature [Internet]. Immunology. 2023 ; 169 323-343.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1111/imm.13631
Vancouver
Fuzo CA, Silva TF de CF, Maruyama SRC, Bastos VAF, Rogerio LA, Takamiya NT, Silva-Neto PV da, Pimentel VE, Toro DM, Pérez MM, Carvalho JCS de, Carmona-Garcia I, Oliveira CNS, Degiovani AM, Ostini FM, Constant LF, Amorim AP de, Vilar FC, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Gaspar GG, Viana AL, Fernandes APM, Santos IKF de M, Russo EM de S, Cardoso CR de B, Sorgi CA, Faccioli LH, Bonato VLD, Baruffi MD. The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature [Internet]. Immunology. 2023 ; 169 323-343.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1111/imm.13631
Artigo de periodico
Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19 (2023)
Toro, Diana Mota; Silva Neto, Pedro Vieira da ; Carvalho, Jonatan Constança Silva de ; Fuzo, Carlos Alessandro ; Pérez, Malena Martínez; Pimentel, Vinícius Eduardo ; Fraga-Silva, Thais Fernanda de Campos ; Oliveira, Camilla N. S; Caruso, Glaucia Rigotto ; Vilela, Adriana Ferreira Lopes ; Azevedo, Pedro Nobre ; Felippe, Thiago Vinicius Defelippo ; Argolo, Jamille Guedes Malta; Degiovani, Augusto Marcussi; Ostini, Fátima M; Feitosa, Marley Ribeiro ; Parra, Rogério Serafim ; Vilar, Fernando C; Gaspar, Gilberto Gambero ; Rocha, José Joaquim Ribeiro da ; Féres, Omar ; Costa, Gabriel Peinado ; Maruyama, Sandra R. C; Russo, Elisa Maria de Sousa ; Fernandes, Ana Paula Morais ; Santos, Isabel Kinney Ferreira de Miranda ; Malheiro, Adriana; Sadikot, Ruxana T; Bonato, Vânia Luiza Deperon ; Cardoso, Cristina Ribeiro de Barros ; Dias-Baruffi, Marcelo ; Trapé, Átila Alexandre ; Faccioli, Lucia Helena ; Sorgi, Carlos Arterio
Source: Cells. Conference titles: ImmunoCovid Consortium Group. Unidades: FMRP, FCFRP, EERP, EEFERP, FFCLRP, Interunidades em Enfermagem
Subjects: BIOMARCADORES, COVID-19, PROGNÓSTICO, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TORO, Diana Mota et al. Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19. Cells, v. 12, n. 15, 2023Tradução . . Disponível em: https://doi.org/10.3390/cells12151938. Acesso em: 29 jan. 2026.
APA
Toro, D. M., Silva Neto, P. V. da, Carvalho, J. C. S. de, Fuzo, C. A., Pérez, M. M., Pimentel, V. E., et al. (2023). Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19. Cells, 12( 15). doi:10.3390/cells12151938
NLM
Toro DM, Silva Neto PV da, Carvalho JCS de, Fuzo CA, Pérez MM, Pimentel VE, Fraga-Silva TF de C, Oliveira CNS, Caruso GR, Vilela AFL, Azevedo PN, Felippe TVD, Argolo JGM, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Costa GP, Maruyama SRC, Russo EM de S, Fernandes APM, Santos IKF de M, Malheiro A, Sadikot RT, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Trapé ÁA, Faccioli LH, Sorgi CA. Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19 [Internet]. Cells. 2023 ; 12( 15):[citado 2026 jan. 29 ] Available from: https://doi.org/10.3390/cells12151938
Vancouver
Toro DM, Silva Neto PV da, Carvalho JCS de, Fuzo CA, Pérez MM, Pimentel VE, Fraga-Silva TF de C, Oliveira CNS, Caruso GR, Vilela AFL, Azevedo PN, Felippe TVD, Argolo JGM, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Costa GP, Maruyama SRC, Russo EM de S, Fernandes APM, Santos IKF de M, Malheiro A, Sadikot RT, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Trapé ÁA, Faccioli LH, Sorgi CA. Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19 [Internet]. Cells. 2023 ; 12( 15):[citado 2026 jan. 29 ] Available from: https://doi.org/10.3390/cells12151938
Artigo de periodico
The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule (2022)
Cordeiro, Jéssica Fernanda Corrêa ; Fernandes, Talita Morais ; Toro, Diana Mota; Silva-Neto, Pedro V. da; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez ; Carvalho, Jonatan Constança Silva de; Fraga-Silva, Thais Fernanda de Campos ; Oliveira, Camilla Narjara Simão; Argolo, Jamille Guedes Malta; Degiovani, Augusto Marcussi; Ostini, Fátima Magro; Puggina, Enrico Fuini ; Silva, João Santana da ; Santos, Isabel Kinney Ferreira de Miranda ; Bonato, Vânia Luiza Deperon ; Cardoso, Cristina Ribeiro de Barros ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena ; Donadi, Eduardo Antônio ; Sorgi, Carlos Arterio ; Fernandes, Ana Paula Morais
Source: International Journal of Molecular Sciences. Unidades: FMRP, FCFRP, FFCLRP, EERP, RUSP, Interunidades em Enfermagem
Subjects: COVID-19, CITOCINAS, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, Jéssica Fernanda Corrêa et al. The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule. International Journal of Molecular Sciences, v. 23, n. 17, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23179736. Acesso em: 29 jan. 2026.
APA
Cordeiro, J. F. C., Fernandes, T. M., Toro, D. M., Silva-Neto, P. V. da, Pimentel, V. E., Pérez, M. M., et al. (2022). The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule. International Journal of Molecular Sciences, 23( 17), 1-16. doi:10.3390/ijms23179736
NLM
Cordeiro JFC, Fernandes TM, Toro DM, Silva-Neto PV da, Pimentel VE, Pérez MM, Carvalho JCS de, Fraga-Silva TF de C, Oliveira CNS, Argolo JGM, Degiovani AM, Ostini FM, Puggina EF, Silva JS da, Santos IKF de M, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Donadi EA, Sorgi CA, Fernandes APM. The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 17): 1-16.[citado 2026 jan. 29 ] Available from: https://doi.org/10.3390/ijms23179736
Vancouver
Cordeiro JFC, Fernandes TM, Toro DM, Silva-Neto PV da, Pimentel VE, Pérez MM, Carvalho JCS de, Fraga-Silva TF de C, Oliveira CNS, Argolo JGM, Degiovani AM, Ostini FM, Puggina EF, Silva JS da, Santos IKF de M, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Donadi EA, Sorgi CA, Fernandes APM. The severity of COVID-19 affects the plasma soluble levels of the immune checkpoint HLA-G molecule [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 17): 1-16.[citado 2026 jan. 29 ] Available from: https://doi.org/10.3390/ijms23179736

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation